Charles Schwab
GTHX

Charles Schwab’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-137,921
Closed -$314K 3624
2024
Q2
$314K Buy
137,921
+116,405
+541% +$265K ﹤0.01% 3358
2024
Q1
$92.9K Hold
21,516
﹤0.01% 3309
2023
Q4
$65.6K Hold
21,516
﹤0.01% 3380
2023
Q3
$31K Sell
21,516
-218,093
-91% -$314K ﹤0.01% 3463
2023
Q2
$597K Buy
239,609
+35,245
+17% +$87.8K ﹤0.01% 2967
2023
Q1
$548K Buy
204,364
+21,246
+12% +$56.9K ﹤0.01% 2923
2022
Q4
$994K Buy
183,118
+2,227
+1% +$12.1K ﹤0.01% 2770
2022
Q3
$2.26M Buy
180,891
+25,576
+16% +$320K ﹤0.01% 2550
2022
Q2
$768K Sell
155,315
-111,030
-42% -$549K ﹤0.01% 2895
2022
Q1
$2.03M Buy
266,345
+5,644
+2% +$42.9K ﹤0.01% 2643
2021
Q4
$2.66M Buy
260,701
+20,568
+9% +$210K ﹤0.01% 2609
2021
Q3
$3.22M Buy
240,133
+329
+0.1% +$4.42K ﹤0.01% 2578
2021
Q2
$5.26M Buy
239,804
+13,054
+6% +$286K ﹤0.01% 2324
2021
Q1
$5.46M Buy
226,750
+25,232
+13% +$607K ﹤0.01% 2256
2020
Q4
$3.63M Buy
201,518
+519
+0.3% +$9.34K ﹤0.01% 2372
2020
Q3
$2.32M Buy
200,999
+1,460
+0.7% +$16.9K ﹤0.01% 2444
2020
Q2
$4.84M Buy
199,539
+13,081
+7% +$317K ﹤0.01% 2047
2020
Q1
$2.06M Buy
186,458
+3,578
+2% +$39.4K ﹤0.01% 2267
2019
Q4
$4.83M Buy
182,880
+3,141
+2% +$83K ﹤0.01% 2031
2019
Q3
$4.1M Buy
179,739
+13,309
+8% +$303K ﹤0.01% 2074
2019
Q2
$5.1M Buy
166,430
+26,079
+19% +$800K ﹤0.01% 1961
2019
Q1
$2.33M Buy
140,351
+5,391
+4% +$89.5K ﹤0.01% 2311
2018
Q4
$2.59M Buy
134,960
+12,042
+10% +$231K ﹤0.01% 2230
2018
Q3
$6.43M Buy
122,918
+79,918
+186% +$4.18M ﹤0.01% 1907
2018
Q2
$1.87M Buy
43,000
+14,100
+49% +$613K ﹤0.01% 2401
2018
Q1
$1.07M Buy
28,900
+14,300
+98% +$530K ﹤0.01% 2493
2017
Q4
$290K Hold
14,600
﹤0.01% 2884
2017
Q3
$364K Buy
+14,600
New +$364K ﹤0.01% 2806